Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 33 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2011Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2011Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismAtkins, G.; Rowe, P.; Lim, H.; Welldon, K.; Ormsby, R.; Wijenayaka, A.; Zelenchuk, L.; Evdokiou, A.; Findlay, D.
2000Involvement of p21Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrateChai, F.; Evdokiou, A.; Young, G.; Zalewski, P.
2000Intracellular zinc depletion induces caspase activation and p21Waf1/Cip1 cleavage in human epithelial cell linesChai, F.; TruongTran, A.; Evdokiou, A.; Young, G.; Zalewski, P.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2002Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosisAtkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.